Showing 1 - 2 results of 2 for search 'Yong-Gyu Son', query time: 0.02s Refine Results
  1. 1
    Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release

    Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release by Eunhee Lee, Yong-Gyu Son, Shinai Lee, Yangmi Lim, Jonghwa Won, Sumyeong Park, Jiseon Yoo, Youngil Koh, Dong-Yeop Shin

    Published 2023-10-01
    Get full text
    Article
  2. 2
    N-terminal selective conjugation method widens the therapeutic window of antibody–drug conjugates by improving tolerability and stability

    N-terminal selective conjugation method widens the therapeutic window of antibody–drug conjugates by improving tolerability and stability by Min Ji Ko, Daehae Song, Juhee Kim, Jae Yong Kim, Jaehyun Eom, Byungje Sung, Yong-Gyu Son, Young Min Kim, Sang Hoon Lee, Weon-Kyoo You, Jinwon Jung

    Published 2021-01-01
    Get full text
    Article

Search Tools: